Findings

What do systematic reviews say?

1,230 questions · 1,303 findings · 326 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 73 · 5.6%GRADE not reported 21 · 1.6%Very low 497 · 38.1%Low 403 · 30.9%Moderate 245 · 18.8%High 64 · 4.9%

Traditional NSAIDs vs placebo

BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
356 participants
High

Traditional NSAIDs vs placebo

BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Traditional NSAIDs vs placebo

Radiographic progression · patients with axSpA (AS and nr‐axSpA)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

COX‐2 NSAIDs vs placebo

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
349 participants
High

Parent‐only interventions vs minimal contact control

Health‐related quality of life (HRQoL) · children with overweight or obesity

1 finding from 1 review

Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 93 participants
GRADE not reported

Parent‐only interventions vs minimal contact control

Parent‐child relationship or assessment of parenting · children with overweight or obesity

1 finding from 1 review

Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 93 participants
Low

Parent‐only interventions vs parent‐only interventions

Parent‐child relationship or assessment of parenting · children with overweight or obesity

1 finding from 1 review

Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
GRADE not reported

Intervention not reported

Quality of life (dyspnoea) Measured on the CRQ, the output is a number from 0 to 7, where higher on the scale is better. MID is 0.5. · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment

The intervention probably leads to higher quality of life (dyspnoea) Measured on the CRQ, the output is a… (moderate certainty).

1 finding from 1 review

Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest 2014 · Cochrane Headline outcomes only
MD 0.28 [0.1, 0.45]
4 studies · 341 participants
Moderate

Intervention not reported

Pain Global pain 0‐3 (higher scores mean worse) · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Intervention not reported

Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Intervention not reported

Function Loss of function 0‐3 (higher scores mean worse) · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Intervention not reported

Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 97 participants
Moderate

Boswellia serrata vs valdecoxib

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Very low

Intervention not reported

Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 651 participants
Moderate

Intervention not reported

Radiographic joint changes Change in Joint Space Width (JSW) from baseline (higher scores mean worse). · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 453 participants
Moderate

Intervention not reported

Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 156 participants
Moderate

Intervention not reported

Function Lequesne algofunctional index 0‐24 (higher scores mean worse) · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 156 participants
Moderate

Persea gratissma + Glycine max (ASU 300 mg) vs chondroitin sulphate

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 357 participants
Low

Persea gratissma + Glycine max (ASU 300 mg) vs chondroitin sulphate

Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 357 participants
Low

Intervention not reported

Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with treating osteoarthritis

1 finding from 1 review

Oral herbal therapies for treating osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 85 participants
Moderate